Home
Antibodies
Cervical Cancer
Our Company
News
Contact Us
International Distributors
Ordering List
Home
Antibodies
Cervical Cancer
Our Company
News
Contact Us
Home
>
Antibodies
>
GeneAb™ VHL Antibody
Coming Soon
Designations
IVD:
RUO:
Reference Panels
Breast/Gynecological Pathology
Dermatopathology
Gastrointestinal (GI) Pathology
Genitourinary (GU) Pathology
Head and Neck Pathology
Hematopathology
Neuropathology
Pediatric Pathology
Pulmonary Pathology
Soft Tissue Pathology
Cytopathology
GeneAb™
VHL
(In the pipeline)
Select Format:
Concentrate
Predilute
Positive Control Slides
Select Volume:
0.1 ml
1 ml
7 ml
25 ml
3 slides/package
Price:
$210.00
Quantity:
Cat. No.
IHC683-100
Inquire
Description
Von Hippel–Lindau tumor suppressor (VHL) is a protein whose mutated form leads to von Hippel–Lindau disease, which is characterized by an upregulation of angiogenesis related factors. VHL is associated with central nervous system hemangioblastomas, clear cell renal carcinomas, and pheochromocytomas.
References
Esteban MA, et al. J Am Soc Nephrol. 2006; 17:1801-6.
Kaelin WG. Clin Cancer Res. 2007; 13:680s-684s.
Specifications
Clone
IHC683
Source
Mouse Monoclonal
Positive Control
Colon and Thyroid Cancer Tissue
Dilution Range
1:100 - 1:400
Literature
Catalog
Data Sheet
SDS Sheet
Recommended products
FSH
(IHC580)
IDH1 R132H
(IHC132)
Tau
(IHC696)
Vimentin
(IHC684)